Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG — Stella

Home/High Grade Glioma/Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

View on ClinicalTrials.gov

Recruiting

Back to High Grade Glioma trials

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

St. Joseph's Hospital and Medical Center, Phoenix, Arizona

Key details

Phase

Very early testing

Sponsor

Nader Sanai

Collaborators

Barrow Neurological Institute, Ivy Brain Tumor Center

Enrollment target

~12 participants

Started

May 2023

Primary completion

May 2026

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.